Scientists have identified an RNA molecule with broad powers to regulate the body's inflammatory response to infection and injury. Called lincRNA-Cox2, it belongs to a recently discovered, highly abundant class of RNAs whose ...
Nov 6, 2018
0
518
Researchers in Brazil have discovered a new effect of a drug widely used as a chemotherapeutic agent and offered to patients free of charge by SUS, the national health service.
Oct 25, 2018
0
2
An environmentally responsible formulation process that makes the immunosuppressant drug, Tacrolimus (TAC) more soluble, and hence more readily absorbed by the body, has been developed by A*STAR scientists.
Oct 4, 2018
0
3
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology. And the pills will reduce their pain as effectively as any powerful drug on the market, according to ...
Sep 12, 2018
0
10
Yale researchers have developed a new imaging technique that captures detailed information about metabolism, which plays a role in many diseases. The novel yet simple technique, which harnesses existing technology, could ...
Aug 23, 2018
0
26
Researchers from the University of Illinois at Chicago have identified a protein that is crucial for activating inflammation—both the good kind of inflammation that leads to healing wounds and fighting infection, as well ...
Jun 27, 2018
0
390
A detailed picture of a brain-boosting experimental drug could one day help researchers tailor it for use in human clinical trials.
Mar 29, 2018
0
319
Using a mathematical modeling approach, scientists have found that certain parameters of tumor growth in mice can predict the effectiveness of drugs that block formation of tumor-nourishing blood vessels. The findings are ...
Dec 21, 2017
0
9
A KAIST research team led by Professor Kwang-Hyun Cho of the Department of Bio and Brain Engineering developed technology to find the optimum drug targets for specific types of cancer cells. The team used systems biology ...
Dec 18, 2017
0
8
Johns Hopkins Kimmel Cancer Center researchers demonstrated that mice with ovarian cancer that received drugs to reactivate dormant genes along with other drugs that activate the immune system had a greater reduction of tumor ...
Dec 5, 2017
0
157
